How is cardiac troponin released from injured myocardium?

European Heart Journal: Acute Cardiovascular Care

Volumn 7, Issue 6, 2018, Pages 553-560

  Mair, Johannes ^a   Lindahl, Bertil ^b   Hammarsten, Ola ^c   Müller, Christian ^d   Giannitsis, Evangelos ^e   Huber, Kurt ^f,g   Möckel, Martin ^h   Plebani, Mario ⁱ   Thygesen, Kristian ^j   Jaffe, Allan S ^k  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f WILHELMINEN HOSPITAL   (Austria)

^g SIGMUND FREUD UNIVERSITY   (Austria)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^j AARHUS UNIVERSITY HOSPITAL   (Denmark)

^k MAYO CLINIC   (United States)

more..

Author keywords

apoptosis; Cardiac troponin I; cardiac troponin T; myocardial injury; necrosis; release; reversible

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CALPAIN; CASPASE 3; DRUG; TOXIN; TROPONIN; TROPONIN I; TROPONIN T;

ACUTE HEART INFARCTION; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; HEART INFARCTION; HEART MUSCLE FIBER MEMBRANE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HEART STRESS; HUMAN; IMAGE ANALYSIS; INFLAMMATION; MEDICAL DECISION MAKING; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PH; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; SENSITIVITY AND SPECIFICITY; UNSTABLE ANGINA PECTORIS; CARDIAC MUSCLE; METABOLISM; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; PATHOLOGY;

APOPTOSIS; BIOMARKERS; HUMANS; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; TROPONIN;

EID: 85050525621     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872617748553     Document Type: Article

References (45)

1. Mair J. Tissue release of cardiac markers: From physiology to clinical applications. Clin Chem Lab Med 1999; 37: 1077–1084
2. Takemura G, Kanoh M, Minatoguchi S. Cardiomyocyte apoptosis in the failing heart – a critical review from definition and classification of cell death. Int J Cardiol 2013; 167: 2373–2386
3. Heyndrickx GR, Millard RW, McRitchie RJ. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975; 56: 978–985
4. Ishikawa Y, Saffitz JE, Mealman TL. Reversible myocardial ischemic injury is not associated with increased creatine kinase activity in plasma. Clin Chem 1997; 43: 467–475
5. Bergmann O, Zdunek S, Felker A. Dynamics of cell generation and turnover in the human heart. Cell 2015; 161: 1566–1575
6. Haubner B, Schneider J, Schweigmann U. Functional recovery of a human neonatal heart after severe myocardial infarction. Circ Res 2016; 118: 216–221
7. Eschenhagen T, Bolli R, Braun T. Cardiomyocyte regeneration: A consensus statement. Circulation 2017; 136: 680–686
8. La Gerche A, Burns AT, Mooney DJ. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 2012; 33: 998–1006
9. Shave R, Oxborough D. Exercise-induced cardiac injury: evidence from novel imaging techniques and highly sensitive cardiac troponin assays. Prog Cardiovasc Dis 2012; 54: 407–415
10. Möhlenkamp S, Leineweber K, Lehman N. Coronary atherosclerosis burden, but not transient troponin elevation, predicts long-term outcome in recreational marathon runners. Basic Res Card 2014; 109: 391
11. Sabatine MS, Morrow DA, de Lermos JA. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischemia using an ultrasensitive assay: Results from TIMI 35. Eur Heart J 2009; 30: 162–169
12. Turer AT, Addo TA, Martin JL. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: Insights from a coronary sinus sampling study. J Am Coll Cardiol 2011; 57: 2398–2405
13. Lee G, Twerenbold R, Tanglay Y. Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia. Am Heart J 2016; 173: 8–17
14. Siriwardena M, Campbell V, Richards AM. Cardiac biomarker responses to dobutamine stress echocardiography in healthy volunteers and patients with coronary artery disease. Clin Chem 2012: 1492–1494
15. Kawahara C, Tsutamoto T, Nishiyama K. Prognostic role of high-sensitivity cardiac troponin T in patients with nonischemic dilated cardiomyopathy. Circ J 2011; 75: 656–661
16. Nassenstein K, Breuckmann F, Bucher C. How much myocardial damage is necessary to enable detection of focal gadolinium enhancement at cardiac MR imaging? Radiology 2008; 249: 829–835
17. Valina CM, Amann M, Stratz C. Predictors of high-sensitivity cardiac troponin in stable patients undergoing coronary angiography. Eurointervention 2016; 12: 329–336
18. Grimsmo J, Grundvold I, Maehlum S. High prevalence of atrial fibrillation in long-term endurance cross-country skiers: Echocardiographic findings and possible predictors – a 28–30 years follow-up study. Eur J Cardiovasc Prev Rehabil 2010; 17: 100–115
19. Sorichter S, Puschendorf B, Mair J. Skeletal muscle injury by eccentric muscle action: Muscle proteins as markers of muscle injury. Exerc Immunol Rev 1999; 5: 5–21
20. Shi X, Garry DJ. Muscle stem cells in development, regeneration, and disease. Genes Dev 2006; 20: 1692–1708
21. Feng J, Schaus BJ, Fallavollita JA. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 2001; 103: 2035–2037
22. Weil BR, Young RF, Shen X. Brief myocardial ischemia produces cardiac troponin I release and focal myocyte apoptosis in the absence of pathological infarction in swine. JACC Basic Transl Sci 2017; 2: 105–114
23. Piper HM, Schwartz P, Spahr R. Early enzyme release from myocardial cells is not due to irreversible cell damage. J Mol Cell Cardiol 1984; 16: 385–388
24. Demonbreun AR, McNally EM. Plasma membrane repair in health and disease. Curr Top Membr 2016,77: 67–96
25. Cooper ST, McNeil PL. Membrane repair: Mechanisms and pathophysiology. Physiol Rev 2015; 95: 1205–1440
26. Hoffstein S, Gennaro DE, Fox AC. Colloidal lanthanum as a marker for impaired plasma membrane permeability in ischemic dog myocardium. Am J Pathol 1975; 79: 207–218
27. Page E, Upshaw-Earley J, Goings G. Permeability of rat atrial endocardium, epicardium, and myocardium to large molecules. Stretch-dependent effects. Circ Res 1992; 71: 159–173
28. Boutet M, Huttner I, Rona G. Permeability alteration of sarcolemmal membrane in catecholamine-induced cardiac muscle cell injury. In vivo studies with fine structural diffusion tracer horse radish peroxidase. Lab Invest 1976; 34: 482–488
29. McNeil PL, Kirchhausen T. An emergency response team for membrane repair. Nat Rev Mol Cell Biol 2005; 6: 499–505
30. Hessel MHM, Atsma DE, van der Valk EJM. Release of cardiac troponin I from viable cardiomyocytes mediated by integrin stimulation. Eur J Physiol 2008; 455: 979–986
31. Hessel MHM, Michielsen ECHJ, Atsma DE. Release kinetics of intact and degraded troponin I and T after irreversible cell damage. Exp Mol Pathol 2008; 85: 90–95
32. Parmacek MS, Solaro RJ. Biology of troponin complex in cardiac myocytes. Prog Cardiovasc Dis 2004; 47: 159–176
33. Katrukha IA. Human cardiac troponin complex. Structure and functions. Biochemistry (Mosc) 2013; 73: 1447–1465
34. Wei B, Jin JP. Troponin T isoforms and posttranscriptional modifications: Evolution, regulation and function. Arch Biochem Biophys 2011; 505: 144–154
35. Remppis A, Scheffold T, Greten J. Intracellular compartmentation of troponin T: Release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995; 27: 793–803
36. Bleier J, Vorderwinkler KP, Falkensammer J. Different intracellular compartmentations of cardiac troponins and myosin heavy chains: A causal connection to their different early release after myocardial damage. Clin Chem 1998; 44: 1912–1918
37. Starnberg K, Jeppsson A, Lindahl B. Revision of the troponin T release mechanism from damaged human myocardium. Clin Chem 2014; 60: 1098–1104
38. De Lisa F, De Tullio R, Salamino F. Specific degradation of troponin T and I by µ-calpain and its modulation by substrate phosphorylation. Biochem J 1995; 308: 57–61
39. Dunn ME, Coluccio D, Hirkaler G. The complete pharmacokinetic profile of serum cardiac troponin I in the rat and the dog. Toxicol Sci 2011; 123: 368–373
40. Friden V, Starnberg K, Muslimovic A. Clearance of cardiac troponin T with and without kidney function. Clin Biochem 2017; 50: 468–474
41. Mair J, Lindahl B, Müller C. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care. Epub ahead of print 1 May 2017. DOI: 10.1177/2048872617708973
42. Möckel M, Giannitsis E, Müller C. Editor’s choice-rule-in of acute myocardial infarction: Focus on troponin. Eur Heart J Acute Cardiovasc Care 2017; 6: 212–217
43. Locca D, Bucciarelli-Ducci C. New universal definition of myocardial infarction – applicable after complex percutaneous coronary intervention? JACC Cardiovasc Interv 2010; 3: 950–958
44. Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410–414
45. Sandoval Y, Apple FS, Smith SW. High-sensitivity cardiac troponin assays and unstable angina. Eur Heart J Acute Cardiovasc Care. Epub ahead of print 7 July 2016. pii: 2048872616658591